Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
Saved in:
| Main Authors: | Dennis Bourdette, Lindsey Wooliscroft |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924000722 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of phosphodiesterase‐4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination
by: Yasir A. Syed, et al.
Published: (2013-10-01) -
Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro
by: Larissa Jank, et al.
Published: (2024-07-01) -
The potential of repurposing clemastine to promote remyelination
by: Reiji Yamazaki, et al.
Published: (2025-05-01) -
Siponimod supports remyelination in the non-supportive environment
by: Johann Krüger, et al.
Published: (2025-02-01) -
Repair mechanisms of the central nervous system: From axon sprouting to remyelination
by: Lauren Gluck, et al.
Published: (2025-07-01)